Kopin to Host 2026 Technology Demo Days Tour in Key U.S. Markets
Select Industry Participants, Investors and Media Invited to Experience Live Demonstrations of Kopin’s Next-Generation Vision System Solutions in New York City,... Read more.
ADOBE, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Adobe, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADBE
NEW YORK–(BUSINESS WIRE)–$ADBE #NASDAQ–Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and... Read more.
Marsh to Host First Quarter Earnings Investor Call on April 16
NEW YORK–(BUSINESS WIRE)–Marsh (NYSE: MRSH), a global leader in risk, strategy and people, will announce first quarter financial results via news release... Read more.
Trex Goes All Out With ‘Performance-Engineered’ Brand Campaign
New creative concepts and high-profile sponsorship integrations amplify brand visibility across major sports and lifestyle platforms WINCHESTER, Va.–(BUSINESS... Read more.
S&P Global Awards Energy Vault Highest ESG Score for Energy Storage Company for Second Straight Year, Energy Vault Publishes 2025 Corporate Sustainability Report
Energy Vault’s 2025 Corporate Sustainability Report reflects fourth consecutive year of ESG score improvements from S&P Global, a comprehensive and industry-specific... Read more.
Radiant Logic Earns Two 2026 Cybersecurity Industry Awards for Identity Security Innovation
Identity Security Provider takes Gold in the 2026 Globee Cybersecurity Awards for IAM and Silver in the 2026 Cybersecurity Excellence Awards for Identity Security... Read more.
Scott Machut Joins Alliant Insurance Services’ Value-Based Healthcare and Risk Management Solutions Team
Machut has 30 years of experience in insurance, reinsurance, and management consulting IRVINE, Calif.–(BUSINESS WIRE)–#AlliantInsurance–Scott Machut... Read more.
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
In early clinical results, Sarepta’s αvβ6 integrin-targeted siRNA approach achieves high muscle concentrations without dose limiting toxicity for FSHD1 and DM1... Read more.
Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome
FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission 30-patient pivotal study initiated, evaluating... Read more.
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
Board to evaluate a range of alternatives while continuing to support core business priorities ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #MASLD—ENDRA... Read more.